| Literature DB >> 35890457 |
Jie Tian1, Xiang-Hong Ke1, Yuan Yuan1, Wen-Xiang Yang1, Xiao-Qiao Tang1, Lan-Jie Pei1, Jun Fan1, Qin Zhuo2, Xiao-Guang Yang2, Jia-Fa Liu1, Bo-Lin Fan1.
Abstract
The aim of the current study was to evaluate the subchronic toxicity of GmDREB3 gene modified wheat in the third generation rats. SPF Wistar rats were fed with transgenic wheat diet (Gm), parental wheat diet (Jimai22) and AIN-93 rodent diet (Control), respectively, for two generations, to produce the third generation rats which were used for this study. The selected fresh weaned offspring rats (20/sex/group) were given the same diet as their parents for 13 weeks. No toxicity-related changes were observed in rats fed with Gm diet in the following respects: clinical signs, body weights, body weight gains, food consumption, food utilization rate, urinalysis, hematology, serum biochemistry and histopathology. The results from the present study demonstrated that 13 weeks consumption of Gm wheat did not cause any adverse effects in the third generation rats when compared with the corresponding Jimai22 wheat.Entities:
Keywords: GmDREB3; genetically modified wheat; rats; subchronic toxicity
Year: 2022 PMID: 35890457 PMCID: PMC9323929 DOI: 10.3390/plants11141823
Source DB: PubMed Journal: Plants (Basel) ISSN: 2223-7747
Figure 1Weekly body weights of female and male animals in three groups. * represents p < 0.05 compared with Jimai22 group; ** represents p < 0.01 compared with Jimai22 group.
Figure 2Weekly food consumption of female and male animals in three groups.
Figure 3Total body weight gains of females and males during 13 weeks. ## represents p < 0.01 compared with control group.
Figure 4Total food consumption of females and males during 13 weeks.
Figure 5Total food utilization of females and males during 13 weeks. ## represents p < 0.01 compared with control group.
Hematological parameters of male and female rats ( ± s, n = 20).
| Sex | Group | WBC | RBC | Hb | LYMP | MONO | NEUT | EO | BAS | HCT | PLT | APTT | PT |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| (×109/L) | (×1012/L) | (g/L) | (%) | (%) | (%) | (%) | (%) | (%) | (%) | (s) | (s) | ||
| Gm | 2.6 ± 1.1 | 7.66 ± 0.51 | 134 ± 32 | 70.0 ± 6.1 | 2.3 ± 0.9 | 25.8 ± 6.1 | 1.9 ± 0.9 | 0.0 ± 0.0 | 40.4 ± 2.2 ## | 817 ± 227 | 11.8 ± 3.7 | 12.9 ± 0.8 | |
| Female | Jimai22 | 2.7 ± 1.2 | 7.75 ± 0.48 | 144 ± 9 | 68.7 ± 4.9 | 2.1 ± 0.8 | 26.6 ± 4.3 | 2.7 ± 2.0 | 0.0 ± 0.0 | 41.3 ± 2.2 | 792 ± 161 | 12.5 ± 5.9 | 12.3 ± 0.5 |
| Control | 2.8 ± 1.2 | 7.91 ± 0.54 | 149 ± 10 | 67.2 ± 8.0 | 2.0 ± 0.8 | 29.0 ± 8.6 | 1.9 ± 0.8 | 0.0 ± 0.0 | 43.7 ± 2.8 | 846 ± 109 | 12.2 ± 0.8 | 12.8 ± 0.5 | |
| Gm | 4.9 ± 1.6 | 8.40 ± 0.28 | 146 ± 5 * | 64.0 ± 4.8 | 2.4 ± 0.6 | 31.2 ± 4.6 | 2.4 ± 0.7 | 0.0 ± 0.0 | 41.7 ± 1.2 **## | 894 ± 90 | 10.9 ± 0.8 | 12.8 ± 2.0 | |
| Male | Jimai22 | 4.9 ± 1.4 | 8.68 ± 0.49 | 151 ± 7 | 60.6 ± 6.9 | 2.8 ± 0.7 | 34.1 ± 6.7 | 2.5 ± 0.8 | 0.0 ± 0.0 | 43.4 ± 1.5 | 881 ± 105 | 11.5 ± 1.1 | 13.0 ± 0.41 |
| Control | 5.5 ± 1.3 | 8.36 ± 0.34 | 148 ± 6 | 63.3 ± 4.5 | 2.2 ± 0.5 | 32.1 ± 4.4 | 2.1 ± 0.8 | 0.0 ± 0.0 | 44.3 ± 1.8 | 863 ± 99 | 12.5 ± 1.6 | 12.9 ± 0.57 |
* represents p < 0.05 compared with Jimai22 group; ** represents p < 0.01 compared with Jimai22 group; ## represents p < 0.01 compared with control group.
Serum chemistry parameters of male and female rats ( ± s, n = 20).
| Sex | Group | Glu | BUN | Cr | CHOL | TG | ALT | AST | TP | ALB | ALB/GLO | K+ | Na+ | Cl− | Ca2+ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| (mmol/L) | (mmol/L) | (μmol/L) | (mmol/L) | (mmol/L) | (U/L) | (U/L) | (g/L) | (g/L) | (mmol/L) | (mmol/L) | (mmol/L) | (mmol/L) | |||
| Gm | 6.03 ± 0.98 # | 4.12 ± 0.57 *## | 64.9 ± 5.5 | 2.04 ± 0.48 **## | 0.50 ± 0.16 a | 31 ± 12 # | 85 ± 18 ## | 60.8 ± 2.6 # | 32.3 ± 1.5 | 1.13 ± 0.05 a | 4.43 ± 1.57 | 140.2 ± 1.4 | 103.1 ± 1.5 | 2.54 ± 0.09 ## | |
| Female | Jimai22 | 6.33 ± 0.95 | 4.72 ± 0.76 | 67.4 ± 7.4 | 1.64 ± 0.35 | 0.57 ± 0.18 a | 29 ± 6 | 86 ± 18 | 61.6 ± 3.0 | 33.1 ± 1.6 | 1.19 ± 0.08 a | 4.00 ± 0.32 | 139.9 ± 1.7 | 103.3 ± 1.4 | 2.53 ± 0.07 |
| Control | 5.21 ± 0.96 | 5.22 ± 1.03 | 68.2 ± 7.9 | 1.59 ± 0.35 | 0.52 ± 0.16 | 39 ± 8 | 113 ± 12 | 58.2 ± 3.6 | 31.3 ± 1.9 | 1.17 ± 0.07 | 4.53 ± 0.52 | 140.0 ± 2.6 | 103.4 ± 1.6 | 2.44 ± 0.08 | |
| Gm | 6.85 ± 0.86 ##a | 4.89 ± 0.55 | 61.4 ± 6.3 | 1.88 ± 0.56 * | 0.60 ± 0.24 | 34 ± 6 a | 85 ± 9 #a | 57.4 ± 2.7 | 28.7 ± 1.2 | 1.00 ± 0.06 | 4.39 ± 0.68 | 139.7 ± 0.8 ## | 100.8 ± 1.5 ## | 2.53 ± 0.08 | |
| Male | Jimai22 | 6.62 ± 0.93 a | 4.71 ± 0.57 | 60.7 ± 5.1 | 1.52 ± 0.35 | 0.74 ± 0.46 | 32 ± 5 a | 90 ± 13 a | 58.2 ± 2.5 | 29.2 ± 1.4 | 1.01 ± 0.09 | 4.39 ± 0.47 | 140.2 ± 1.0 | 101.2 ± 1.6 | 2.52 ± 0.07 |
| Control | 5.85 ± 0.84 | 4.51 ± 0.59 | 58.0 ± 4.5 | 1.76 ± 0.46 | 0.83 ± 0.38 | 38 ± 7 | 94 ± 12 | 57.7 ± 2.3 | 28.5 ± 1.01 | 0.98 ± 0.05 | 4.37 ± 0.34 | 143.2 ± 1.1 | 103.0 ± 1.2 | 2.50 ± 0.04 |
* represents p < 0.05 compared with Jimai22 group; ** represents p < 0.01 compared with Jimai22 group; # represents p < 0.05 compared with control group; ## represents p < 0.01 compared with control group; a represents this data was cited in our last paper (Tian et al., 2021) [15].
Organ weights and relative organ weights of females ( ± s, n = 20).
| Organ | Gm | Jimai22 | Control | |||
|---|---|---|---|---|---|---|
| Weights | Relative Weights (%) | Weights | Relative Weights (%) | Weights | Relative Weights (%) | |
| Body weight | 354.2 ± 36.4 | 348.4 ± 33.1 | 302.0 ± 28.2 | |||
| Heart | 1.02 ± 0.13 # | 0.288 ± 0.034 | 1.02 ± 0.11 | 0.293 ± 0.029 | 0.93 ± 0.11 | 0.310 ± 0.035 |
| Liver | 9.32 ± 1.14 **## | 2.648 ± 0.378 ** | 8.29 ± 0.84 | 2.379 ± 0.099 | 7.91 ± 1.04 | 2.631 ± 0.370 |
| Spleen | 0.75 ± 0.10 # | 0.213 ± 0.022 | 0.71 ± 0.09 | 0.205 ± 0.020 | 0.66 ± 0.10 | 0.220 ± 0.034 |
| Kidneys | 2.11 ± 0.018 ## | 0.598 ± 0.056 | 2.06 ± 0.23 | 0.592 ± 0.059 | 1.89 ± 0.15 | 0.630 ± 0.061 |
| Brain | 1.89 ± 0.25 | 0.538 ± 0.088 ## | 1.89 ± 0.06 | 0.546 ± 0.056 | 1.87 ± 0.08 | 0.623 ± 0.059 |
| Uterus | 0.62 ± 0.21 | 0.178 ± 0.068 | 0.70 ± 0.29 | 0.203 ± 0.084 | 0.61 ± 0.17 | 0.202 ± 0.056 |
| Ovaries | 0.21 ± 0.03 | 0.061 ± 0.009 # | 0.21 ± 0.04 | 0.059 ± 0.009 | 0.22 ± 0.04 | 0.073 ± 0.017 |
| Adrenals | 0.103 ± 0.024 * | 0.030 ± 0.007 * | 0.085 ± 0.018 | 0.024 ± 0.005 | 0.094 ± 0.026 | 0.031 ± 0.009 |
| Thymus | 0.461 ± 0.078 ## | 0.131 ± 0.023 | 0.424 ± 0.139 | 0.122 ± 0.037 | 0.353 ± 0.086 | 0.117 ± 0.029 |
* represents p < 0.05 compared with Jimai22 group; ** represents p < 0.01 compared with Jimai22 group; # represents p < 0.05 compared with control group; ## represents p < 0.01 compared with control group.
Organ weights and relative organ weights of males ( ± s, n = 20).
| Organ | Gm | Jimai22 | Control | |||
|---|---|---|---|---|---|---|
| Weights | Relative Weights (%) | Weights | Relative Weights (%) | Weights (g) | Relative Weights (%) | |
| Body weight | 587.1 ± 44.1 | 585.7 ± 69.5 | 524.0 ± 43.6 | |||
| Heart | 1.49 ± 0.14 | 0.254 ± 0.023 # | 1.52 ± 0.17 | 0.261 ± 0.027 | 1.44 ± 0.17 | 0.275 ± 0.030 |
| Liver | 15.08 ± 1.80 | 2.577 ± 0.327 a | 14.80 ± 2.64 | 2.518 ± 0.254 a | 14.32 ± 1.31 | 2.740 ± 0.218 |
| Spleen | 1.11 ± 0.19 | 0.189 ± 0.030 | 1.05 ± 0.17 | 0.179 ± 0.021 | 1.17 ± 0.55 | 0.224 ± 0.103 |
| Kidneys | 3.46 ± 0.28 | 0.592 ± 0.055 a | 3.38 ± 0.41 | 0.579 ± 0.048 a | 3.25 ± 0.58 | 0.625 ± 0.122 |
| Brain | 2.10 ± 0.08 | 0.359 ± 0.033 # | 2.09 ± 0.09 | 0.361 ± 0.046 | 2.05 ± 0.08 | 0.394 ± 0.039 |
| Testis | 4.03 ± 0.53 | 0.688 ± 0.092 | 3.93 ± 0.81 | 0.672 ± 0.109 | 4.06 ± 1.18 | 0.773 ± 0.199 |
| Epididymides | 1.67 ± 0.19 | 0.287 ± 0.040 | 1.61 ± 0.21 | 0.278 ± 0.051 | 1.72 ± 0.62 | 0.329 ± 0.118 |
| Prostate | 1.49 ± 0.25 | 0.253 ± 0.038 | 1.51 ± 0.26 | 0.262 ± 0.058 | 1.39 ± 0.25 | 0.265 ± 0.043 |
| Adrenals | 0.090 ± 0.021 | 0.015 ± 0.004 | 0.084 ± 0.020 | 0.014 ± 0.003 | 0.091 ± 0.025 | 0.018 ± 0.005 |
| Thymus | 0.594 ± 0.168 | 0.101 ± 0.028 | 0.571 ± 0.152 | 0.097 ± 0.023 | 0.503 ± 0.119 | 0.096 ± 0.024 |
# represents p < 0.05 compared with control group; a represents this data was cited in our last paper (Tian et al., 2021) [15].
Histopathological results of three groups at week 13.
| Histopathological Lesions | Groups | |||||
|---|---|---|---|---|---|---|
| Gm Group | Jimai22 Group | Control Group | ||||
| Sex | ♀ | ♂ | ♀ | ♂ | ♀ | ♂ |
| Number | 20 | 20 | 20 | 20 | 20 | 20 |
|
| ||||||
| Slight interstitial inflammation | 0 | 0 | 1 | 0 | 0 | 0 |
|
| ||||||
| Slight glandular dilatation | 0 | 0 | 0 | 1 | 0 | 0 |
|
| ||||||
| Slight inflammatory cell infiltration | 0 | 1 | 1 | 1 | 0 | 0 |
| Slight vacuolation | 1 | 0 | 0 | 1 | 0 | 0 |
| Severe vacuolation | 0 | 0 | 0 | 1 | 0 | 0 |
|
| ||||||
| Slight interstitial inflammatory cell infiltration | 0 | 1 | 1 | 0 | 0 | 1 |
| Slight hyaline casts | 2 | 2 | 2 | 1 | 1 | 1 |
| Slight calcium deposition | 2 | 0 | 1 | 0 | 1 | 0 |
|
| ||||||
| Severe atrophy | - | 1 | - | 2 | - | 1 |
|
| ||||||
| Sperm loss | - | 1 | - | 2 | - | 1 |
“-”: Not applicable.
Figure 6Non-specific histopathological changes in rats at week 13. (A): slight interstitial inflammation of lung in Jimai22 group; (B): Slight glandular dilatation of stomach in Jimai22 group; (C): slight inflammatory cells infiltration of liver in Jimai22 group; (D,E): slight hepatic vacuolation in Jimai22 and Gm group; (F–H): slight renal interstitial inflammatory cell infiltration in Control, Jimai22 and Gm group, respectively; (I,J): Slight renal hyaline casts in Jimai22 group and Gm group; (K–M): slight renal calcium deposition in Control, Jimai22 and Gm group, respectively; (N–P): testicular atrophy in Control, Jimai22 and Gm group, respectively; (Q,R): epididymal sperm loss in Control, Jimai22 group.